Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 05, 2024

BUY
$26.21 - $29.22 $12,161 - $13,558
464 Added 0.64%
73,042 $2.05 Million
Q3 2023

Nov 02, 2023

BUY
$26.26 - $31.38 $30,304 - $36,212
1,154 Added 1.62%
72,578 $1.97 Million
Q2 2023

Aug 09, 2023

BUY
$29.6 - $36.56 $29,156 - $36,011
985 Added 1.4%
71,424 $2.2 Million
Q1 2023

May 03, 2023

BUY
$32.77 - $39.4 $2.31 Million - $2.78 Million
70,439 New
70,439 $2.54 Million

Others Institutions Holding RPRX

About Royalty Pharma plc


  • Ticker RPRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 437,139,008
  • Market Cap $10.6B
  • Description
  • Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...
More about RPRX
Track This Portfolio

Track Beck Bode, LLC Portfolio

Follow Beck Bode, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Beck Bode, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Beck Bode, LLC with notifications on news.